Vancouver, BC, November 29, 2019--Phoenix Molecular Designs(PhoenixMD), a clinical stage biotechnology company developing precise cancer therapeutics targeting essential kinases, announced that it has dosed the first patient in its Phase 1/1b study of PMD-026, the company's lead product candidate.
Phoenix Molecular Designs
Vancouver (Biotech/Life Sciences) 0-9 Employees In BC (10-19 Employees Total)
Founded: 2012
Phoenix Molecular designs is a biotechnology company that is developing game changing small molecule kinase inhibitors as a targeted therapy for Cancer.
Vancouver, BC, October 9, 2019--Phoenix Molecular Designs(PhoenixMD), a clinical stage biotechnology company developing precise cancer therapeutics targeting essential kinases, received clearance from the Food and Drug Administration (FDA) for PhoenixMD's Investigational New Drug (IND) application for its proprietary PMD-026.
Phoenix Molecular Designs
Vancouver (Biotech/Life Sciences) 0-9 Employees In BC (10-19 Employees Total)
Founded: 2012
Phoenix Molecular designs is a biotechnology company that is developing game changing small molecule kinase inhibitors as a targeted therapy for Cancer.
Vancouver, BC, July 25, 2019--Phoenix Molecular Designs(PhoenixMD), a privately-held biotechnology company designing precise cancer therapeutics targeting essential kinases, has announced the recent completion of clinical trial supply manufacture for PMD-026.
Phoenix Molecular Designs
Vancouver (Biotech/Life Sciences) 0-9 Employees In BC (10-19 Employees Total)
Founded: 2012
Phoenix Molecular designs is a biotechnology company that is developing game changing small molecule kinase inhibitors as a targeted therapy for Cancer.
Vancouver, BC, March 28, 2019--Phoenix Molecular Designs(PhoenixMD), a privately-held biotechnology company designing precise cancer therapeutics by targeting essential kinases, announced this week the appointment of Magda Marquet, Ph.D., to its Board of Directors.
Phoenix Molecular Designs
Vancouver (Biotech/Life Sciences) 0-9 Employees In BC (10-19 Employees Total)
Founded: 2012
Phoenix Molecular designs is a biotechnology company that is developing game changing small molecule kinase inhibitors as a targeted therapy for Cancer.
Vancouver, BC, January 28, 2019--Phoenix Molecular Designs (PhoenixMD), a privately-held biotechnology company designing precise cancer therapeutics by targeting essential kinases, announced that it has entered into a collaboration with Roche to develop a diagnostic (CDx) in triple-negative breast cancer (TNBC).
Phoenix Molecular Designs
Vancouver (Biotech/Life Sciences) 0-9 Employees In BC (10-19 Employees Total)
Founded: 2012
Phoenix Molecular designs is a biotechnology company that is developing game changing small molecule kinase inhibitors as a targeted therapy for Cancer.
Vancouver, BC, May 1, 2018--Phoenix Molecular Designs (PhoenixMD), a privately-held biotechnology company designing precise cancer therapeutics by targeting essential kinases, announced that it has entered into a collaboration with STA Pharmaceutical Co., Ltd (STA), a WuXi AppTec group company, to manufacture the PMD-026 needed for IND-enabling toxicology studies and a Phase I study in women.
Phoenix Molecular Designs
Vancouver (Biotech/Life Sciences) 0-9 Employees In BC (10-19 Employees Total)
Founded: 2012
Phoenix Molecular designs is a biotechnology company that is developing game changing small molecule kinase inhibitors as a targeted therapy for Cancer.
Vancouver, BC, July 21, 2017--Phoenix Molecular Designs (PhoenixMD), a privately-held biotechnology company designing precise cancer therapeutics by targeting essential kinases, announced today the appointment of Dr. Gerrit Los as Chief Scientific Officer and a member of the executive management team.
Phoenix Molecular Designs
Vancouver (Biotech/Life Sciences) 0-9 Employees In BC (10-19 Employees Total)
Founded: 2012
Phoenix Molecular designs is a biotechnology company that is developing game changing small molecule kinase inhibitors as a targeted therapy for Cancer.
News
Events
Tech Careers
Directory
Tech Stocks
T-Net 100
Members
Feedback
About T-Net
Employers
Post Job Listings
Advertise
